Triumph Research Intelligence (www.tritrials.com), a subsidiary of Triumph Consultancy Services (www.triumphconsultancy.com), is looking for energetic web application developers that want to apply knowledge and experience to the creation of a leading edge web application for the clinical trials industry. Our product, OPRA, is growing and to keep up with the demand we need to expand our team. If you…
Our client, Advanced Clinical a successful, forward looking CRO who were seeing increasing demand from sponsors to offer quality oversight and central monitoring in accordance with the incoming ICH E6 (R2) guidance. Advanced Clinical wanted to ensure they had both the processes and technology needed to be able to offer and articulate this capability as part of any future…
TRI has been selected as a member of this year’s group of MCC Champions – a special honor bestowed upon individuals who made significant contributions in 2016 to advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials. As the Metrics Champion Consortium (MCC) passes its ten year anniversary, the original mission has stayed the…
As we at TRI continue to engage with industry on RBM implementation, I am pleased with the observations that we are currently making across a range of CRO and Pharma companies. Rolling back the clock 18-24 months and most of the discussions we were having with customers and prospects were about risk detection, data visualisation and stats models. For…
(Expired) Successful risk-based monitoring extends well beyond just risk detection. The clinical R&D industry needs to deliver on the promise of quality improvement and cost reduction both operationally and from a regulatory perspective. We must be able to show evidence that due planning and oversight has taken place during a study by building an audit trail of the way…
(Expired) This webinar will give a brief summary of the concept and purpose of the OPRA RBM platform, followed by a detailed system demonstration of the features and functions. We will wrap up with an open question and answer session, where you will be able to address questions to TRI’s management team. Please follow the link below to register…
(Expired) Learn how OPRA has been designed to support the four pillars of RBM: Identify, Manage, Mitigate and Report. See the new features in the latest evolution of OPRA, and learn how TRI are continually improving the system in order to support any company wishing to benefit from quality oversight and risk-based monitoring. Who should attend: Existing customers of…
(Expired) Within this webinar, we will: – Illustrate the process of using the outputs of protocol risk assessment to identify protocol risk indicators – Illustrate the process of designing protocol risk indicators – Explore the characteristics of good indicators of site quality risk – Explore the practical application of surrogate risk indicators in RBM
(Expired) This webinar will be presented by TRI Founder and CEO, Duncan Hall and will cover the following: – Getting started with risk assessment – Identifying / designing risk indicators – Quality oversight and management – Risk mitigation – Practical application of technology to support all stages of RBM
(Expired) ICH GCP E6 revision 2 is due to be finalized this summer and implemented later this year. The impact on any company running clinical trials is going to be significant. Companies need to start planning now to ensure adequate time for change management and implementation to occur. This free webinar, focusing on quality management, will allow companies to quickly…
1. Background Triumph Research Intelligence (TRI) was founded as a subsidiary of Triumph Consultancy Services in 2013, following 12 years of consulting to the clinical trial industry. Over the past 12 months TRI has been evaluating the specific challenges facing the industry when implementing a risk-based monitoring strategy and the various approaches and products being utilized by organizations as…
Why? If a company wants to take a risk-based approach to monitoring, it must be able to prove it has a quality risk management plan which it executed, measured, and adjusted over time. How? TRI developed a purpose built application based on industry guidance that identifies site quality risk and allows central management of monitoring and risk mitigation activities What? OPRA…
(Expired) Protocol Risk Assessment – limited attendance Why is this webinar so important? Protocol Risk Assessment is the genesis of the new Quality Management section (5) of ICH E6 (R2) and core to the principles of quality by design (QBD). It drives much of the downstream quality planning and management activity during the course of a clinical trial and…
TransCelerate’s Risk-Based Monitoring (RBM) project has been productive in the first half of 2014. The purpose of RBM Update Volume II is to share new and relevant information on the accomplishments of the RBM workstream including the following: RACT version 2.0 released on April 29, 2014 Central Monitoring Capability Technology Considerations to Enable RBM External Engagement Upcoming Deliverables in…
